Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-03-14
1996-12-24
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 62, A61K 31715, A61K 3169
Patent
active
055873634
ABSTRACT:
A therapeutic composition for the protection, treatment and repair of connective tissue in humans and animals and a method for the treatment of connective tissue in humans and animals by the administration of the composition. The composition includes aminosugars and glycosaminoglycans.
REFERENCES:
patent: 3232836 (1966-02-01), Carlozzi et al.
patent: 3371012 (1968-02-01), Furuhashi
patent: 3683076 (1972-08-01), Rovati
patent: 3697652 (1972-10-01), Rovati et al.
patent: 4006224 (1977-02-01), Prudden
patent: 4486416 (1984-12-01), Soll et al.
patent: 4801619 (1989-01-01), Lindblad
patent: 4983580 (1991-01-01), Gibson
patent: 5141928 (1992-08-01), Goldman
Bucci, et al, Chondroprotective Agents Glucosamine Salts and Chondroctin Sulfate, Townsend Letters for Doctors, Jan. 1994, pp. 52-58.
Rejholec, V, Long Terms Studies of Antaostooarthritic Drugs Co. pp. 35-53 assessment, Seminars in Arthritis & Rheumatism, vol. 17, No. 2, Suppl. (1987).
M. Adam et al., Anzneim.-Forsch./Drug Res., 30(II) (10) :1730-1732 (1980).
Morrison, et al, "Coronary Heart Disease and the Mucopolysaccharides (Glycosaminoglycans)", C. C. Thomas, Publisher, 1974, pp. 109-127.
Drovanti et al, "Therapeutic Activity of Oral Glucosamine Sulfate in Osteoarthrosis; A Placebo-Controlled Double-Blind Investigation", Clin. Therap. 3 (4) 260-272 (1980).
Karzel et al, "Effects of Hexosamine Derivatives and Uronic Acid Derivatives on Glycosaminoglycane Metabolism of Fibroblast Cultures", Pharmacol. 5, 337-345 (1971).
Setnikar et al, "Pharmakinetics of Glucosamine in the Dog and in Man", Arzneimittelforschung 38 (2) 729-736 (1991).
Vidal y Plana et al, "Articular Cartilage Pharmacology: I. In Vitro Studies on Glucosamine and Non-Steroidal Anti-inflammatory Drugs", Pharm. Res. Comm., 10 (6) 557-569 (1978).
Anon., "Using a Chondroprotective Drug in Treating Dogs With Osteochondrosis", Veterin. Med., 130 (1993).
Bucci, "Manganese: Its Role in Nutritional Balance", Today's Chirop., 17 (2) 23-28, 44 (1988).
Bucci, "Glucosamine-A New Potent Nutraceutical For Connective Tissues", The Nutritional Supplement Advisor, Jul. 1992.
Banks, "Applied Veterminary Histology", Williams and Wilkins Publisher, pp. 84-85 (1986).
"Current Therapy in Equine Medicine", Robinson, Editor, W. B. Saunders Co., Publisher, pp. 402-403 (1987).
Garrison, Jr., et al, "The Nutrition Desk Reference", Keats Publishing, Inc., pp. 70-71 (1985).
Christensen, "Nutritional Support For Injury Rehabilitation Specific Needs For The Three Phases of Rehabilitation", Chiropractic Products, pp. 8-10, Sep. 12, 1993.
Murray, "A Natural Treatment of Osteoarthritis", MPI's Dyanmic Chiropractic, pp. 8-10, Sep. 12, 1993.
Bucci, "Chondroproductive Agents Glucosamine Salts and Chondroitin Sulfates", Townsend Letters for Doctors, pp. 52-54, Jan. 1994.
Colgan "Glucosamine Saves Your Joints", Muscular Development, Fitness Health, vol. 31, No. 8, p. 24 (Aug. 1994).
Criares Theodore J.
Nutramax Laboratories, Inc.
LandOfFree
Aminosugar and glycosaminoglycan composition for the treatment a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminosugar and glycosaminoglycan composition for the treatment a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminosugar and glycosaminoglycan composition for the treatment a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1178600